Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
Login to comment.